Metastatic Breast Cancer News Monitoring

Vepdegestrant Demonstrates Progression-Free Survival in Patients With ER+/HER2- Metastatic Breast Cancer

Vepdegestrant (ARV-471; Arvinas, Inc) met its primary end point of progression-free survival (PFS) compared with fulvestrant (Faslodex; AstraZeneca) in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/ …

Vepdegestrant Hits PFS End Point in ESR1-Mutated, ER+/HER2– Metastatic Breast Cancer

Treatment with vepdegestrant (ARV-471) led to a statistically significant and clinically meaningful improvement in progression-free survival (PFS) vs fulvestrant (Faslodex) in patients with estrogen receptor (ER)–positive, HER2-negative advanced or …

Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued ...

SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, today announced its strategic decision …

Atirmociclib Plus Letrozole Demonstrates Preliminary Efficacy and Safety in HR+/HER2-Negative Metastatic Breast Cancer

A preliminary analysis of an ongoing phase 1/2a study (NCT04557449) evaluating the safety, tolerability, and efficacy of atirmociclib (PF-07220060) in combination with letrozole demonstrated preliminary antitumor activity and a favorable safety profile …

First-Line T-DXd ± Pertuzumab Yields Durable Responses in HER2+ Metastatic Breast Cancer

First-line treatment with fam-trastuzumab deruxtecan (T-DXd; Enhertu) with or without pertuzumab (Perjeta) generated responses in patients with HER2-positive metastatic breast cancer, according to updated data from the phase 1b/2 DESTINY-Breast07 trial …

Alisertib Plus Endocrine Therapy Is Under Evaluation in HR+/HER2-Negative Metastatic Breast Cancer

The ongoing phase 2 ALISCA-Breast1 study (NCT06369285) is evaluating the efficacy, safety, and optimal dose of alisertib (MLN8237) in combination with endocrine therapy in patients with hormone receptor (HR)–positive, HER2-negative recurrent or metastatic …

Vepdegestrant Meets PFS Primary End Point in ESR1m ER+/HER2– Breast Cancer

Vepdegestrant (ARV-471) monotherapy elicited a statistically significant progression-free survival (PFS) vs fulvestrant (Faslodex) in patients with ESR1-mutant advanced or metastatic breast cancer who experienced disease progression after treatment with …

Dr Heldermon on a Phase 1/2 Trial Design of Epidiferphane Plus a Taxane in Breast Cancer

“We’re doing [a pharmacokinetics] analysis 1 hour, 2 hours, and 12 hours post-chemotherapy and looking at circulating cytokines that are associated with neuropathy as well as other immune responses, just to make sure that we are not adversely affecting the …

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

The first patient with metastatic human epidermal growth factor receptor 2-positive (HER2+) breast cancer has been enrolled in the HEROES clinical trial exploring the discontinuation or de-escalation of anti-HER2-targeted therapy. “The HEROES study could …

Four Things to Remember When Both Spouses Have Cancer

It’s a real challenge when either a husband and wife or a partner and significant other have cancer. We go through all sorts of emotions, from rage and depression to losing hope and regaining hope. It’s very important that we find ways to support each …

Stakeholders Unite to Address Policy Barriers to Breast Cancer Care

Susan G. Komen convenes new Alliance for Breast Cancer Policy WASHINGTON, March 12, 2025 /PRNewswire/ -- Susan G. Komen, the world's leading breast cancer organization, today launched the Alliance for Breast Cancer Policy, a bold initiative …

Heidi Ruth Meissner

Share Tweet Share Share Email Comments WESTFIELD – Heidi Ruth Meissner, 57, passed away unexpectedly March 10, 2025, at Baystate Medical Center, battling metastatic breast cancer. Heidi was born January 12, 1968, at Noble Hospital in Westfield, MA and was …

Dr Kalinsky on the Potential to Switch CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer

"We have data from various studies—in particular the [phase 3] postMONARCH study [NCT05169567]—that helped establish that there could potentially be a role for switching endocrine therapy and, for the most part, switching a CDK4/6 inhibitor." …

Expert Perspectives From DESTINY-PanTumor 02 and Real-World Experience with Trastuzumab Deruxtecan in HER2-Positive BTC

MT-8421 Displays Acceptable Safety Profile in First-in-Human Trial for Advanced Solid Tumors SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors SAR443216 Engages HER2 With Manageable Toxicity in Advanced …

PF-07248144 Plus Fulvestrant Is Safe, Active in Pretreated ER+/HER2– Metastatic Breast Cancer

Treatment with the first-in-class KIT6 inhibitor PF-07248144 in combination with fulvestrant (Faslodex) produced durable responses and was safe in patients with heavily pretreated estrogen receptor (ER)–positive, HER2-negative metastatic breast cancer, …

Cancer a family battle; mother and daughter speak out

Advocate for funding for biomarker testing, early detection, casino smoking ban OCEAN CITY — Jeanmarie Mason is battling breast cancer. Her daughter is fighting cervical cancer. Her husband was diagnosed with prostate cancer. In spite of the challenging …

Phesgo Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, And Trends

The Business Research Company's Phesgo Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 12, 2025 /⁨EINPresswire.com⁩/ -- Is the Phesgo Market Poised for Significant …

Understanding Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

Arvinas & Pfizer announce positive topline results from phase 3 VERITAC─2 clinical trial

Arvinas, Inc., a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases, and Pfizer Inc. announced positive topline results from the phase 3 VERITAC-2 clinical trial ( …

Shaenfield Pediatric Dentistry Welcomes New Dentist Dr. Natalia Velasquez to Their Team

Shaenfield Pediatric Dentistry is excited to announce the addition of Dr. Natalia Velasquez to their dental team, enhancing their pediatric dental services. SAN ANTONIO, TX, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Shaenfield Pediatric …

Tots to Teens Marks 13 Years of Dental Care in Underserved Areas

From One to Five Locations: A Journey of Commitment and Comprehensive Pediatric Dental Services SAN ANTONIO, TX, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Tots to Teens Pediatric Dentistry & Orthodontics proudly marks its 13th …

The Guardian Group, LLC announces Fellowship Trained Orthopaedic Surgeon: Brett Fink, MD, QME

Dr. Brett Fink has joined The Guardian Group as a Qualified Medical Evaluator (QME) with exams locations in California in the specialty of Orthopaedic Surgery SANTA ANA, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Brett Fink, MD, QME …

The Guardian Group, LLC announces Psychiatrist Timothy MacDonald, MD, QME

Dr. Timothy MacDonald has joined The Guardian Group as a Qualified Medical Evaluator (QME) with exams locations across California in the specialty of Psychiatry SANTA ANA, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Dr. Timothy …

The Guardian Group, LLC announces Psychiatrist: Sean Awakuni, MD, QME

Dr. Sean Awakuni has joined The Guardian Group as a Qualified Medical Evaluator (QME) in the specialty of Psychiatry SANTA ANA, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Sean Awakuni, MD, QME is a Board-Certified Psychiatrist who …

Pinpoint Management Launches “AI-Driven Leadership: The Next Era Series” to Transform Business Growth

New Webinar Series Equips Leaders with AI-Powered Strategies to Scale, Innovate, and Empower Their Teams SALT LAKE CITY, UT, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Pinpoint Management, a leader in business consulting and operational …

March is Save Your Vision Month: Acupuncture Offers Hope for Better Eye Health

Dr. Mary Papa, an Arizona acupuncturist, discusses benefits of acupuncture for eye health. She offers solutions for conditions like macular degeneration. FOUNTAIN HILLS, AZ, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- As March ushers in …

GetHairMD™ to Host Aesthetic Party and Showcase Hair Growth Solutions at Major Austin Industry Events

Leading hair growth brand GetHairMD™ brings innovation to Austin this March with conference presentation, exhibition booth, and Texas-style celebration event. SOUTHLAKE, TX, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- In an industry …

Nasal Polyps Treatment Market Set to Surge to $4.24 Billion by 2030 at a 5.6% CAGR

The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030, registering a CAGR of 5.6% from 2021 to 2030. WILMINGTON, DE, UNITED STATES, March 13, 2025 /⁨EINPresswire.com⁩/ -- As of 2020, the global nasal polyps …

Knee Replacement Devices Market Set to Surge to $12.3 Billion by 2031 at a 3.4% CAGR

The knee replacement devices market is projected to reach $12.3 billion by 2031, growing at a CAGR of 3.4% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, March 13, 2025 /⁨EINPresswire.com⁩/ -- The global knee replacement devices market has …

Dermatologicals Market Set to Surge to $59.31 Billion by 2030 at a 11.5% CAGR

The global dermatologicals market is expected to reach $59.31 billion by 2030, growing at a CAGR of 11.5% from 2021 to 2030. WILMINGTON, DE, UNITED STATES, March 13, 2025 /⁨EINPresswire.com⁩/ -- In 2020, the global dermatologicals market was …

Neonatal Hearing Screening Device Market to Reach US$ 68.5 Million by 2034, Growing at a 4.90% CAGR

Analysis of Neonatal Hearing Screening Device Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan MD, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- The neonatal hearing …

MEDIA ADVISORY: SWEET LIFE CANNA CO. RIBBON CUTTING

SWEET LIFE CANNA CO. RIBBON CUTTING: Rare Chance to see the inside of a medical cannabis cultivation facility. LONG BEACH , MS, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Sweet Life Canna Co. Ribbon Cutting Ceremony Set for March 14, 10 …

Dr. Robert Krasnick Now Offering Shockwave Therapy (ESWT) for Chronic Pain in Ann Arbor, MI

Introducing ESWT: A Non-Invasive Solution for Chronic Pain at Krasnick Regenerative Medicine​ ANN ARBOR, MI, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Krasnick Regenerative Medicine, led by Dr. Robert Krasnick, is excited to announce …

90 Years of Laughs, Colonoscopies, and Reinvention Took Over Times Square, Captivating Readers Everywhere

ORANGEBURG, SC, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- In a landmark moment for author and physician David S. Cantor, his memoir, My Life Uninterrupted: 90 Years of Laughs, Colonoscopies, and Reinvention, has been featured on a Times …

The Best Work Goes Unnoticed: A Conversation with Dr. Layliev

NEW YORK, NY, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- When it comes to cosmetic dentistry, the ultimate goal is to create a result so seamless that it goes unnoticed—appearing as though nature itself designed the perfect smile. We sat …

SPECTRAFORCE Named One of SIA’s 2025 Best Staffing Firms to Work For

Minority-owned staffing firm builds excellent relationship-driven culture. RALEIGH, NC, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- SPECTRAFORCE, an innovative workforce solutions firm, is proud to announce that it has been recognized as …

Matthew Keider, DDS Launches New Website Featuring Comprehensive Patient Education Resources in Winston-Salem, NC

Dr. Matthew Keider launches www.KeiderDDS.com, a patient education website with videos, 24/7 live chat, & online scheduling for dental care in Winston-Salem, NC WINSTON-SALEM, NC, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Matthew Keider, …

Disposable Endoscopes Market Set to Surge to $5.4 Billion by 2031 at a 16.4% CAGR

In 2021, the global disposable endoscopes market was valued at $1.2 billion and is projected to reach $5.4 billion by 2031, exhibiting a CAGR of 16.4%. WILMINGTON, DE, UNITED STATES, March 13, 2025 /⁨EINPresswire.com⁩/ -- In 2021, the global …

New Frontiers Introduces Episode Featuring the Fly Little Bird Foundation Airing March 15th on Bloomberg: The content in ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. The Fly Little Bird Foundation in New Frontiers Episode on March 15th on Bloomberg. EXCELSIOR, MN, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Planet …